About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,800 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,800 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 561-580 of 10,800 trials

CompletedCombination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute LeukemiaPhase I trial to study the effectiveness of PSC-833 plus etoposide and mitoxantrone in treating children who have refractory or relapsed acute leukemia.NCT00002912·Little Rock, Arkansas and 54 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedA Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor MalignanciesThis is an open-label, randomized, single-dose, 2-treatment, 2-period, 2-way crossover study with incomplete wash-out in subjects with solid tumors to determine the relative…NCT01725100·Goodyear, Arizona and 3 others

TerminatedPilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast CancerThis is a pilot "window of opportunity" clinical study in patients with operable breast cancer investigating use of reparixin as single agent in the time period between clinical…NCT01861054·Indianapolis, Indiana and 8 others

CompletedComparative Safety and Efficacy of Two Treatments in the Treatment of Acne VulgarisThe purpose of this study is to compare the safety and efficacy of Perrigo's product to an FDA approved product for the treatment acne vulgarisNCT02515305·Nashville, Tennessee

CompletedRituximab, Lenalidomide, and Bortezomib in Mantle Cell LymphomaThis is a Phase I/II multicenter, open-label, dose-escalation study of rituximab, bortezomib, and lenalidomide in the first-line or second-line treatment of patients with Mantle…NCT00633594·Terre Haute, Indiana and 6 others

CompletedMEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.The objective of this study is to evaluate the safety, tolerability, and antitumor activity of oleclumab (MEDI9447) in combination with or without durvalumab plus chemotherapy in…NCT03611556·La Jolla, California and 26 others

CompletedA Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular EdemaThis is a multicenter long-term extension study designed to evaluate the long-term safety and tolerability of faricimab administered by intravitreal (IVT) injection at a…NCT04432831·Mesa, Arizona and 319 others

CompletedAZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung CancerThis is a phase Ib/II, open-label multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumour activity of AZD9150 plus durvalumab alone or…NCT03421353·Lafayette, Indiana and 5 others

RecruitingCytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant CandidatesThis is a multi-center clinical trial in Cytomegalovirus (CMV) seronegative prospective liver transplant recipients to determine the efficacy of two doses of…NCT06075745·Birmingham, Alabama and 17 others

CompletedStudy Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMSThe purpose of this study is to determine whether LNG/EE is effective in the treatment of menstrual cycle related symptoms.NCT00161681·Huntsville, Alabama and 47 others

RecruitingEffect of 2-HOBA in Persistent Immune Activation in Long COVID POTSLong COVID is defined by a range of symptoms affecting multiple organs that persist for more than three months following an acute SARS-CoV-2 infection.NCT07189936·Nashville, Tennessee

RecruitingA Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)This study is for adults with multiple myeloma (a type of blood cancer) that has come back after being treated earlier or isn't responding to the current treatment.NCT07227311·Los Alamitos, California and 58 others

TerminatedEffects of PA-1 Transcriptional Regulation on Monocyte FunctionResearching genetic differences in people with no prior medical conditions for better understanding of cardiac diseases through genetic research.NCT00512369·Nashville, Tennessee

CompletedPhase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaThe purpose of this study is to test the effectiveness (how well the drug works), safety, and tolerability of the investigational drug combination of palbociclib (Ibrance) plus…NCT03194373·Indianapolis, Indiana and 2 others

TerminatedA Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative ColitisA Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Study to Assess Efficacy and Safety of SER-287 in Adults with Active Mild-to-Moderate Ulcerative ColitisNCT03759041·Phoenix, Arizona and 92 others

RecruitingJUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: BevacizumabThis is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in hospitalized adults…NCT06701656·Birmingham, Alabama and 40 others

TerminatedA Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent GliomaOncoGel™ is a new, experimental drug delivery system that allows the slow continuous release of paclitaxel (an approved intravenous anticancer drug), from a gel (ReGel™) over a…NCT00479765·Chicago, Illinois and 4 others

CompletedA National Registry of Patients With Hepatocellular CarcinomaA registry of patients with the diagnosis of hepatocellular carcinoma.NCT00178867·Nashville, Tennessee

CompletedDisruptive bEhavior manageMEnt ANd Prevention in Hospitalized Patients Using a behaviORal Intervention TeamThe purpose of the proposed study is to evaluate the impact of a behavioral intervention team (BIT) on 2 adult units: a general medical (8N); a cardiac/medical stepdown (8S) at…NCT03777241·Nashville, Tennessee

RecruitingA Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.The purpose of this study is to learn about the safety and effects of the study medicine PF-07248144 when given along with fulvestrant for the possible treatment of HR-positive…NCT07062965·Chandler, Arizona and 201 others

PreviousPage 29 of 540Next

Diabetes

in Nashville

Heart Diseasein Nashville